How many Rapid Dose Therapeutics (PK) shares are in issue?
Rapid Dose Therapeutics (PK) has 124,636,166 shares in issue.
What is the market cap of Rapid Dose Therapeutics (PK)?
The market capitalisation of Rapid Dose Therapeutics (PK) is USD 22.62 M.
What is the 1 year trading range for Rapid Dose Therapeutics (PK) share price?
Rapid Dose Therapeutics (PK) has traded in the range of US$ 0.0021 to US$ 0.39 during the past year.
What is the PE ratio of Rapid Dose Therapeutics (PK)?
The price to earnings ratio of Rapid Dose Therapeutics (PK) is -5.20.
What is the cash to sales ratio of Rapid Dose Therapeutics (PK)?
The cash to sales ratio of Rapid Dose Therapeutics (PK) is 21.95.
What is the reporting currency for Rapid Dose Therapeutics (PK)?
Rapid Dose Therapeutics (PK) reports financial results in CAD.
What is the latest annual turnover for Rapid Dose Therapeutics (PK)?
The latest annual turnover of Rapid Dose Therapeutics (PK) is CAD 1.02M.
What is the latest annual profit for Rapid Dose Therapeutics (PK)?
The latest annual profit of Rapid Dose Therapeutics (PK) is CAD -4.31M.
What is the registered address of Rapid Dose Therapeutics (PK)?
The registered address for Rapid Dose Therapeutics (PK) is 1121 WALKER'S LINE, UNIT 3A, BURLINGTON, ONTARIO, L7N 2G4.
What is the Rapid Dose Therapeutics (PK) website address?
The website address for Rapid Dose Therapeutics (PK) is rapid-dose.com.
Which industry sector does Rapid Dose Therapeutics (PK) operate in?
Rapid Dose Therapeutics (PK) operates in the UNIT INV TR, CLOSED-END MGMT sector.
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
